Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative immune function and postoperative recovery in elderly cancer patients
ChiCTR2300070655Phase 4Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in cancer (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoints: Blood immune cell transcriptome and Blood plasma proteome. Started Apr 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
cancer
Beyond the preview
Go deeper on ChiCTR2300070655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070655.